Canada markets open in 7 hours 49 minutes

Revive Therapeutics Ltd. (RVVTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0204-0.0010 (-4.67%)
At close: 03:07PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.50M
Enterprise Value 6.10M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.05
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.43

Trading Information

Stock Price History

Beta (5Y Monthly) -0.22
52-Week Change 3-60.00%
S&P500 52-Week Change 323.57%
52 Week High 30.0640
52 Week Low 30.0160
50-Day Moving Average 30.0215
200-Day Moving Average 30.0249

Share Statistics

Avg Vol (3 month) 3289.74k
Avg Vol (10 day) 3180.41k
Shares Outstanding 5358.45M
Implied Shares Outstanding 6388.78M
Float 8353.21M
% Held by Insiders 11.46%
% Held by Institutions 10.04%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-16.44%
Return on Equity (ttm)-45.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.51M
Net Income Avi to Common (ttm)-4.3M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)708.41k
Total Cash Per Share (mrq)0
Total Debt (mrq)156.05k
Total Debt/Equity (mrq)1.64%
Current Ratio (mrq)0.31
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-4.1M
Levered Free Cash Flow (ttm)-3.02M